Biotechnology company focused on discovering and developing therapeutics, particularly for rare and immune-mediated diseases
Biotechnology company focused on discovering and developing therapeutics, particularly for rare and immune-mediated diseases. Its proprietary technology analyzes and engineers complex sugars and glycosylated biomolecules to support novel drug discovery, improve existing medicines, and investigate disease pathways. Momenta was acquired by Johnson & Johnson in 2020.